{'52WeekChange': -0.17663044,
 'SandP52WeekChange': None,
 'address1': '419 Davis Drive',
 'address2': 'Suite 100',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 5.54,
 'askSize': 3000,
 'averageDailyVolume10Day': 454450,
 'averageVolume': 383033,
 'averageVolume10days': 454450,
 'beta': None,
 'beta3Year': None,
 'bid': 5.51,
 'bidSize': 900,
 'bookValue': 0.767,
 'category': None,
 'circulatingSupply': None,
 'city': 'Morrisville',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 6.07,
 'dayLow': 5.51,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -3.424,
 'enterpriseToRevenue': 19.126,
 'enterpriseValue': 154389488,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fax': '919 328 4402',
 'fiftyDayAverage': 8.162,
 'fiftyTwoWeekHigh': 12.1,
 'fiftyTwoWeekLow': 2.65,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 18759115,
 'forwardEps': -1.8,
 'forwardPE': -3.0777779,
 'fromCurrency': None,
 'fullTimeEmployees': 64,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'headSymbol': None,
 'heldPercentInsiders': 0.26247,
 'heldPercentInstitutions': 0.47035,
 'industry': 'Biotechnology',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/liquidia.com',
 'longBusinessSummary': 'Liquidia Technologies, Inc., a late-stage clinical '
                        'biopharmaceutical company, focuses on the development '
                        'and commercialization of novel products which utilize '
                        'PRINT technology to transform the lives of patients. '
                        'Its lead product candidate, LIQ861, an inhaled dry '
                        'powder formulation of treprostinil that is in Phase '
                        'III clinical trials used for the treatment of '
                        'pulmonary arterial hypertension. The company is also '
                        'developing LIQ865, which completed Phase 1 clinical '
                        'trials for the treatment of local post-operative '
                        'pain. It has collaboration agreement with the '
                        'University of North Carolina. Liquidia Technologies, '
                        'Inc. was founded in 2004 and is headquartered in '
                        'Morrisville, North Carolina.',
 'longName': 'Liquidia Technologies, Inc.',
 'market': 'us_market',
 'marketCap': 209116720,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_22761611',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -48608144,
 'nextFiscalYearEnd': 1640908800,
 'open': 6,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': None,
 'phone': '919 328 4400',
 'previousClose': 6.06,
 'priceHint': 2,
 'priceToBook': 7.222946,
 'priceToSalesTrailing12Months': 25.906048,
 'profitMargins': 0,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 6.07,
 'regularMarketDayLow': 5.51,
 'regularMarketOpen': 6,
 'regularMarketPreviousClose': 6.06,
 'regularMarketPrice': 6,
 'regularMarketVolume': 453530,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 37746700,
 'sharesPercentSharesOut': 0.0677,
 'sharesShort': 1922086,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 990568,
 'shortName': 'Liquidia Technologies, Inc.',
 'shortPercentOfFloat': 0.1114,
 'shortRatio': 4.79,
 'startDate': None,
 'state': 'NC',
 'strikePrice': None,
 'symbol': 'LQDA',
 'threeYearAverageReturn': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -2.252,
 'twoHundredDayAverage': 6.4214387,
 'underlyingExchangeSymbol': None,
 'underlyingSymbol': None,
 'uuid': '4e9d716d-8a04-3fbc-8a5a-0151bfd0dd75',
 'volume': 453530,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.liquidia.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '27560'}